Smart Fibers Could Allow T-Shirts to Analyze Electrolytes and Metabolites in Sweat
|
By LabMedica International staff writers Posted on 23 Jan 2023 |

Fibers and fabrics have become an integral part of our daily lives, although much remains unchanged for them despite centuries of human progression. Nevertheless, recent advancements in the multi-material fiber drawing process have led to the development of new multifunctional, fiber-based smart fabrics. Smart fabrics make it possible to seamlessly integrate electronics, optics, biosensors, and mechanics into a thin strand of fiber that is intrinsically flexible and as thin as the human hair. Such fabrics can then be used for monitoring the vital physiological signals related to human mental and physical health.
Now, a team of researchers at Tohoku University (Sendai, Japan) has developed a microelectronic fiber with microscopic parameters that is capable of analyzing electrolytes and metabolites in sweat. The micrometer scale of the microelectronic fiber enables it to be woven into clothes for healthcare applications. The researchers developed the microelectronic fiber by leveraging the versatile thermal drawing process, in which heat is applied to draw out micro-structured fiber from its macroscopic preform. The researchers also patterned on two sensing electrodes for sodium and uric acid on the longitudinal surface of the fiber.
Mainstream photolithography and printing technology have made wearable electronics possible, although this generally requires the attachment of fairly rigid electronic patches to the existing fabrics or directly on the skin, resulting in just a small area of the body being covered. The new microelectronic fiber could pave the way for fiber-based smart clothes that offer more versatility in terms of functions, larger sensing areas, and greater comfort. The new smart fabric could revolutionize the textile and healthcare industries, according to the researchers, benefiting the overall society.
"Our breakthrough is the first successful attempt at using thermally drawn fiber in wearable bioelectronics for monitoring biochemical signatures," said Dr. Yuanyuan Guo, assistant professor at Tohoku University's Frontier Research Institute for Interdisciplinary Sciences, who led the research team.
Related Links:
Tohoku University
Latest Clinical Chem. News
- New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
- Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
- Study Compares Analytical Performance of Quantitative Hepatitis B Surface Antigen Assays
- Blood Test Could Predict and Identify Early Relapses in Myeloma Patients
- Compact Raman Imaging System Detects Subtle Tumor Signals
- Noninvasive Blood-Glucose Monitoring to Replace Finger Pricks for Diabetics
- POC Breath Diagnostic System to Detect Pneumonia-Causing Pathogens
- Online Tool Detects Drug Exposure Directly from Patient Samples
- Chemical Imaging Probe Could Track and Treat Prostate Cancer
- Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
- VOCs Show Promise for Early Multi-Cancer Detection
- Portable Raman Spectroscopy Offers Cost-Effective Kidney Disease Diagnosis at POC
- Gold Nanoparticles to Improve Accuracy of Ovarian Cancer Diagnosis
- Simultaneous Cell Isolation Technology Improves Cancer Diagnostic Accuracy
- Simple Non-Invasive Hair-Based Test Could Speed ALS Diagnosis
- Paper Strip Saliva Test Detects Elevated Uric Acid Levels Without Blood Draws
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
New Tool Maps Chromosome Shifts in Cancer Cells to Predict Tumor Evolution
As tumors grow, cancer cells constantly make errors during DNA copying and division. Many of these errors involve the gain or loss of entire chromosomes, resulting in a diverse range of chromosome configurations... Read more
World's First Blood Test Distinguishes Between Benign and Cancerous Lung Nodules
Lung cancer remains the deadliest cancer in China, largely because many patients are diagnosed at an advanced stage when treatment options are limited. Early symptoms are often mild or absent, and while... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channelAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read more
New Test Measures How Effectively Antibiotics Kill Bacteria
Antibiotics are typically evaluated by how well they inhibit bacterial growth in laboratory tests, but growth inhibition does not always mean the bacteria are actually killed. Some pathogens can survive... Read morePathology
view channel
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read more
AI Algorithms Improve Genetic Mutation Detection in Cancer Diagnostics
Accurately identifying genetic mutations is central to cancer diagnostics and genomic research, but current methods struggle with complex sequencing data and limited clinical samples. Tumor analysis often... Read moreIndustry
view channel
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







